Trials / Completed
CompletedNCT02391883
Hip-Fracture Surgery on Patients in Clopidogrel Therapy
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 356 (actual)
- Sponsor
- Hvidovre University Hospital · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Patients in Clopidogrel therapy alone or in combination with acetylsalicylic acid (Dual Antiplatelet Therapy (DAPT) presenting with a hip-fracture represent the surgeon with the dilemma of putting the patient at risk of a major blood loss during and after surgery, or putting the patient at risk of a thromboembolic event after surgery. The investigators hypothesize that the risk of a major blood loss in patients that are still under the effect of Clopidogrel or DAPT during or after hip-fracture surgery is relatively low. The investigators have conducted a retrospective observational study on hip-fracture patients to test this hypothesis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Clopidogrel |
Timeline
- Start date
- 2011-01-01
- Primary completion
- 2013-12-01
- Completion
- 2015-02-01
- First posted
- 2015-03-18
- Last updated
- 2015-03-18
Source: ClinicalTrials.gov record NCT02391883. Inclusion in this directory is not an endorsement.